Discover cutting-edge studies on carcinogenesis, biomarkers, and targeted therapeutic approaches
Exploring phospa-trastuzumab, a bifunctional methylenephosphonate-based chelator that's advancing cancer theranostics with radiometals 89Zr, 111In, and 177Lu.